Viral Infections

  • Author: Jin S. Suh, MD, FACP; Humberto R. Jimenez, PharmD, BCPS, AAHIVP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/21 (What's New)

References

Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al; CAPRISA 004 Trial Group. Effectiveness and safety of vaginal microbicide 1% tenofovir gel for prevention of HIV infection in women. Science. 2010;329:1168-1174.[Abdool Karim 2010]

Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop. 2001;34:239-242.[Aguiar 2001]

Agyemang E, Le QA, Warren T, et al. Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting. Sex Transm Dis. 2017;44:763-767.[Agyemang 2017]

Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS. 1998;12:1149-1154....

Action required